2024-04-25 02:19:58
The Korea Health Industry Association held its inaugural general meeting and academic seminar at the Korea Institute of Oriental Medicine in Yuseong-gu, Daejeon on the 23rd. Je-pil Yoon, director of Phil Oriental Medicine Hospital, who was elected as the first president, said on this day, “One of the key tasks to solve various social structural problems such as low birth rate and aging that Korean society faces is to actively foster and advance the health industry.” “Technology development through advanced research and policy support for stable growth of promising companies are needed,” he said. He continued, “Based on a sense of responsibility and calling, the association will actively contribute to policy proposals based on organic cooperation between industry, academia, research, and disease and communication with government agencies.” He said.
The association supports △ joint research and development in the health industry △ support for education and professional talent development for the development of the health industry △ support for cooperation among member companies to discover business models and create business value △ promotion of global business by providing networking opportunities between members and member companies. Support △The goal is to support the development of artificial intelligence and big data health industry services based on biohealth technology.
At the academic seminar hosted by the Korea Institute of Oriental Medicine’s BIG Project Group and the Korea Brain Health Association and sponsored by Phil Oriental Medicine Hospital and Daejeon Oriental Medicine Hospital’s Brain and Nerve Center, Lee Jin-hyung, a professor of biotechnology at Stanford University in the U.S., and Kang Min-gu, head of the Daejeon City Biohealth Industry Department, participated as presenters.
‘Neuro Match’, developed by Professor Lee, is an artificial intelligence (AI)-based platform that can analyze brain circuits and is a cutting-edge technology that is attracting attention around the world. Neuromatch is expected to contribute to the development of therapeutic drugs, medical devices, and information technology (IT) in the future because it can identify which part of the brain is problematic by producing a ‘digital twin’ of the patient’s brain.
Manager Kang said, “Daejeon is home to the Daedeok Research Complex cluster, led by the Korea Advanced Institute of Science and Technology (KAIST), and is a city with the largest number of bio ventures in the country, making it a perfect city to grow into a mecca for the health industry.” “I hope the industry association will play a big role in helping Daejeon grow into a world-class biocluster,” he said.
On this day, Professor Ho-ryong Ryu of the Brain and Nerve Center at Daejeon Oriental Medicine Hospital, Professor Do-heon Lee of KAIST, Yong-jin Kim, president of the Daejeon Oriental Medicine Association, Ian, director of Woori Deul Nokji International Hospital, Si-woo Lee, director of Korea Institute of Oriental Medicine, Jin-seok Moon, director of Korea Institute of Oriental Medicine, Hyung-il Choi, president of Korea Brain Health Association, and Beom-yong Lee of Emedi Healthcare. Representatives and others attended.
Jinhan Lee, medical reporter and doctor [email protected]
-
- great
- 0dog
-
- I’m so sad
- 0dog
-
- I’m angry
- 0dog
-
- I recommend it
- dog
Hot news now
2024-04-25 02:19:58